Methotrexate treatment protocols and the central nervous system: Significant cure with significant neurotoxicity

Journal of Child Neurology

Volumn 15, Issue 9, 2000, Pages 573-580

  Shuper, Avinoam ^a   Stark, Batya ^a   Kornreich, Liora ^b   Cohen, Ian J ^a   Aviner, Shraga ^a   Steinmetz, Adam ^a   Stein, Jeremiah ^a   Goshen, Yaacov ^a   Yaniv, Isaac ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; FOLINIC ACID; HYDROCORTISONE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; ATAXIA; CANCER CHEMOTHERAPY; CATATONIA; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONFUSION; DRUG MECHANISM; FEMALE; GAIT DISORDER; HUMAN; INTRACTABLE EPILEPSY; LEUKOENCEPHALOPATHY; MALE; MENTAL DETERIORATION; MUSCLE WEAKNESS; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; PARESTHESIA; PRIORITY JOURNAL; SHIVERING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLURRED SPEECH; SPINAL CORD DISEASE;

ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CASE REPORT; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; LEUCOVORIN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033799358     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001500902     Document Type: Article

References (40)

1. Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia
2. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate dose intravenous methotrexate and intrathecal triple therapy - A Pediatric Oncology Study Group study
3. Neurotoxicity (NT) in patients with standard-risk acute lymphoblastic leukemia (ALL) in Pediatric Oncology Group (POG) 9405: A preliminary report
4. Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine and BCNU protocol (DEMOB)
5. The effect of photon irradiation on blood brain barrier permeability to methotrexate in mice
6. Neurotoxicity due to central nervous system therapy for childhood leukemia
7. Paraplegia following intrathecal cytosine arabinoside
8. High-dose Ara-C-related leukoencephalopathy
9. 'Rescue' techniques in cancer chemotherapy: Use of leucovorin and other rescue agents after methotrexate treatment
10. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia
11. Extended intrathecal triple therapy for preventing CNS relapse in non-very-high-risk childhood acute lymphoblastic leukemia treated with the Israeli Protocols INS-84 and -89 (modified BFM-86)
12. Central nervous system pharmacology of antileukemic drugs
13. Neurotoxicity and elevated cerebrospinal fluid methotrexate concentration in meningeal leukemia
14. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies
15. Elevation of homocysteine and excitatory amino acids and neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer
16. A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities
17. Impairment of cerebral biogenic amine synthesis in a patient receiving high-dose methotrexate
18. Neurotoxicite precoce du methotrexate a haute dose et deficit en tetrahydrobiopterine
19. Substitutive therapy in a case of methotrexate neurotoxicity
20. Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia
21. Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphoblastic leukemia
22. Transient ischemic cerebral lesions during induction chemotherapy for acute ymphoblastic leukemia
23. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate
24. Atypical MRI findings in treatment-related leukoencephalopathy: Case report
25. Studies of cerebral blood flow in children with acute lymphoblastic leukemia: Case reports of six children treated with methotrexate examined by single photon emission computed tomography
26. Paraplegia following intrathecal methotrexate. Report of a case and review of the literature
27. Intrathecal methotrexate overdose
28. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia
29. Cerebrovascular accidents in children with cancer
30. Focal encephalopathy following methotrexate therapy
31. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia
32. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study
33. Neuropsychologic effects of chemotherapy on children with cancer: A longitudinal study
34. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate and systemic methotrexate in childhood cancer
35. Progression of methotrexate-induced leukoencephalopathy in children with leukemia
36. CNS late effects after ALL therapy in childhood. Part II: Conventional EEG recordings in asymptomatic long-term survivors of childhood ALL - An evaluation of the interferences between neurophysiology, neurology, psychology and CNS morphology
37. Nerve lesions after therapy for childhood acute lymphoblastic leukemia
38. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials
39. Methotrexate-induced leukoencephalopathy is treatable with high-dose folinic acid: A case report and analysis of the literature